Guillaume Spaccaferri

Mr. Guillaume Spaccaferri

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2022 in Infectious Diseases Now
Verified
Journal Article
Open access
AMAnna Maisa
Anna Maisa
GSGuillaume Spaccaferri
Guillaume Spaccaferri
LFL. Fournier
L. Fournier
JSJustine Schaeffer
Justine Schaeffer
JDJ. Deniau
J. Deniau
YYY. Yazdanpanah
Y. Yazdanpanah
We aimed to investigate the first Omicron cases detected in France in order to assess case characteristics and provide supporting information on the possible impact of this variant on the healthcare system. A standardized questionnaire was used to collect information from confirmed and probable Omicron cases. Median age of 468 investigated cases was 35 years, 376 were symptomatic (89%); 64% were vaccinated with two doses and 7% had received three doses. Loss of smell and taste were reported by 8.3% and 9% of cases, respectively. Seven cases were hospitalized, three of those were unvaccinated (including two with reported precondition). No admissions to intensive care and no deaths were reported. Our results confirm a mild clinical presentation among the first Omicron cases detected in France and highlight the importance for the national COVID-19 surveillance system to quickly detect and adapt to the emergence of a new variant.

11 May 2023 in Viruses
Verified
Journal Article
Open access
PDF file
Sébastien LhommeSébastien Lhomme
Sébastien Lhomme
SMSébastien Magne
Sébastien Magne
SPSylvie Perelle
Sylvie Perelle
EVEmmanuelle Vaissière
Emmanuelle Vaissière
FAFlorence Abravanel
Florence Abravanel
GSGuillaume Spaccaferri
Guillaume Spaccaferri
The identification of seven cases of hepatitis E virus infection in a French rural hamlet in April 2015 led to investigations confirming the clustering and identifying the source of the infection. Laboratories and general practitioners in the area actively searched for other cases based on RT-PCR and serological tests. The environment, including water sources, was also checked for HEV RNA. Phylogenetic analyses were performed to compare HEV sequences. No other cases were found. Six of the seven patients lived in the same hamlet, and the seventh used to visit his family who lived there. All HEV strains were very similar and belonged to the HEV3f subgenotype, confirming the clustering of these cases. All the patients drank water from the public network. A break in the water supply to the hamlet was identified at the time the infection probably occurred; HEV RNA was also detected in a private water source that was connected to the public water network. The water flowing from the taps was quite turbid during the break. The private water supply containing HEV RNA was the likely source of the contamination. Private water supplies not disconnected from the public network are still frequent in rural areas, where they may contribute to public water pollution.

7 April 2024 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
CKCatarina Krug
Catarina Krug
ECEmilie Chazelle
Emilie Chazelle
ATArnaud Tarantola
Arnaud Tarantola
HNHarold Noël
Harold Noël
GSGuillaume Spaccaferri
Guillaume Spaccaferri
YSYvan Souares
Yvan Souares

11 October 2021 in BMC Public Health
Verified
Journal Article
Open access
PDF file
GSGuillaume Spaccaferri
Guillaume Spaccaferri
CCClémentine Calba
Clémentine Calba
PVPascal Vilain
Pascal Vilain
LGLoïc Garras
Loïc Garras
CDCécile Durand
Cécile Durand
PRPatrick Rolland
Patrick Rolland
Background: In France, the lifting of the lockdown implemented to control the COVID-19 first wave in 2020 was followed by a reinforced contact-tracing (CT) strategy for the early detection of cases and transmission chains. We developed a reporting system of clusters defined as at least three COVID-19 cases, within seven days and belonging to the same community or having participated in the same gathering, whether they know each other or not. The aim of this study was to describe the typology and criticality of clusters reported between the two lockdowns in France to guide future action prioritisation. Methods: In this study we describe the typology and criticality of COVID-19 clusters between the two lockdowns implemented in France (between May and end of October 2020). Clusters were registered in a national database named “MONIC” (MONItoring des Clusters), established in May 2020. This surveillance system identified the most affected communities in a timely manner. A level of criticality was defined for each cluster to take into consideration the risk of spreading within and outside the community of occurrence, and the health impact within the community. We compared the level of criticality according to the type of community in which the cluster occurred using Pearson’s chi-square tests. Results: A total of 7236 clusters were reported over the study period, particularly in occupational environment (25.1%, n = 1813), elderly care structures (21.9%, n = 1586), and educational establishments (15.9%, n = 1154). We show a shift over time of the most affected communities in terms of number of clusters. Clusters reported in occupational environment and the personal sphere had increased during summer while clusters reported in educational environment increased after the start of the school year. This trend mirrors change of transmission pattern overtime according to social contacts. Among all reported clusters, 43.1% had a high level of criticality with significant differences between communities (p < 0.0001). A majority of clusters had a high level of criticality in elderly care structures (82.2%), in disability care centres (56.6%), and health care facilities (51.7%). Conclusion: These results highlight the importance of targeting public health action based on timely sustained investigations, testing capacity and targeted awareness campaigns. The emergence of new SARS-CoV-2 variants strengthen these public health recommendations and the need for rapid and prioritise vaccination campaigns.

1 June 2017 in Medecine Et Maladies Infectieuses
Verified
Journal Article
Closed access
KTK. Tararbit
K. Tararbit
ATA. Thabuis
A. Thabuis
GSGuillaume Spaccaferri
Guillaume Spaccaferri
CCC. Cros
C. Cros
NPN. Paquet
N. Paquet
DDD. Dejour-Salamanca
D. Dejour-Salamanca